Vermont Biosciences Alliance Summer Newsletter

Summer Newsletter 
VBSA was created to foster recognition of medicine and bioscience as a leading industry in the Vermont region and promote economic and human well-being by strengthening sector attention, research resources, and venture growth. To the businesses and organizations who are currently members, thank you for supporting the bioscience industry in Vermont.

Save the date! The final 2019 Bio & Tech Beer will be December 5th from 5:00 to 7:00 pm at Queen City Brewery, 703B Pine Street, Burlington. Registration will be available on our events page:  VBSA Events.
NERIC will be held August 14th to 16th at Mount Washington Hotel, NH. For more information check here: NERIC 2019
Save the date! The SBIR Road Tour will stop in Burlington on September 16th at UVM's Davis Center. The SBIR Road Tour is an opportunity for local attendees to speak directly to federal program managers who administer "America's Seed Fund". For updates and more information check here:  SBIR Road Tour
Don't miss a whirlwind week of biotech exhibits, speakers, events, and networking on September 9th to 12th at the Boston Convention and Exhibition Center in Boston, MA.
Industry News
Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment:
Agilent Technologies of Santa Clara, CA, has signed an agreement to acquire VBSA member BioTek Instruments. Briar Alpert, CEO of BioTek, anticipates a natural fit between the two companies, noting that both are committed to growth and excellence in the cell analysis sector as well as to caring for their employees and customers. Agilent intends to keep the BioTek team in Vermont with a minimum of disruptions or changes.
Many Vermont companies are already tapping into markets overseas to expand their growth potential and customer base, but exporting isn't without challenges, from language barriers to compliance and regulation rules. This VMEC's ExporTech program helps enrolled businesses address these challenges, whether a company is new to exporting or is seeking to expand their global presence.
VMEC ExporTech
Education News
UVM's new President, Suresh Garimella, shared remarks with local media on his first day on the job. Garimella stated that he was drawn to UVM by its excellent programs, outstanding students, faculty, and staff, and its status as a land grant institution. He has set student success, continued academic quality, and affordability as his top priorities moving forward.
New UVM President
Vermont is a member of the Institutional Development Award (IDeA) Program, which seeks to broaden the geographic distribution of NIH funding for biomedical research. The IDeA-state entrepreneurship program (I-Trep) is a new NIH-supported education program based in Vermont. Continuing with our mission to provide training and education in biomedical entrepreneurship, the I-Trep program is offering paid specialized internships for 2019-2020. The internships aim to provide career development for faculty, postdoctoral fellows, and students from any Vermont-based academic institution and foster business-research collaborations within Vermont.

Eligible hosts include any bioscience-based business or other businesses such as law offices or consultant firms that support the bioscience community. Terms of the internship are meant to be flexible to accommodate the desired career skill development or business-research partnership goals. The intern will be paid through the I-Trep grant and internships will be a maximum of 12 weeks in duration. Host organizations may submit nominations for candidates who they have already identified or contact the program to see if there are any candidates that fit the host organization's needs.

If your organization would like to participate, please contact Tina Thornton (, coordinator for the I-Trep program, for more information.
Celdara Medical Launches New Website for Biomedical Entrepreneurs

Celdara Medical, LLC today announced the launch of an online resource database for biomedical entrepreneurs: This database was developed by the DRIVEN Accelerator Hub, an NIH-funded consortium led by Celdara Medical including 10 of the leading research institutions in the Northeast region (NH, VT, ME, DE, and RI). The database is open to biomedical entrepreneurs globally and contains resources from across the country. New resources are added by user submission and curated by DRIVEN.
Through the online database, DRIVEN works to serve biomedical entrepreneurs by providing curated, easy-to-access educational resources. Users can filter by location, web resource, date added to site, user type (e.g. undergrad, grad, postdoc, faculty), type of resource (e.g. expert/coach, networking, webinar, workshop), and the type of skills the resource provides (e.g. project management, leadership, accounting, regulatory, finance).  
The DRIVEN Accelerator Hub is funded by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number UT2GM130176. The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About DRIVEN Accelerator Hub
The DRIVEN Accelerator Hub is an NIH-funded consortium led by Celdara Medical and includes partnerships with leading research institutions in the Northeast region (Brown, Dartmouth, Maine Medical Center, MDI Biological Laboratory, Simbex, University of DE, University of NH, University of RI, University of VT). The mission of the DRIVEN Accelerator Hub is to create quality-adjusted life years (QALYs) and save lives by 1) Increasing the number of quality medical startups 2) Decreasing their time to market and 3) Increasing their probability of success.
In addition to the online resource database, DRIVEN provides tailored consulting to select entrepreneurs through the DRIVEN Partnership Program that culminates in a presentation to the DRIVEN External Advisory Committee, comprised of leading investors and in-licensing professionals. At the conclusion of the program, participants are invited to apply for DRIVEN funding to support pivotal studies. For more information regarding the partnership program, email

About Celdara Medical, LLC
Celdara Medical gives hope and health to patients by transforming academic innovations into medicines with the potential to cure the world's most challenging diseases. Celdara Medical is a recognized leader with a rich stable of discoveries, developed in concert with premiere research institutions in the US, EU, and beyond. We secure lasting partnerships with inventors and their institutions, and provide the developmental, financial, and business acumen to bridge the gaps between discovery and clinical impact. With robust funding options, operations in greater Boston, NYC, and Washington, DC, growing affiliates in Seattle and Indianapolis, a wealth of opportunities in our pipeline, and partnerships with industry leaders worldwide, Celdara Medical navigates the path from science to medicine, accelerating innovation to improve human health.

Membership:  Have friends at other businesses that are interested in bioscience and entrepreneurship in Vermont? Invite them to join the VBSA! Joining the VBSA sends a message of support for Vermont bioscience companies and organizations.   Click here   for more on the benefits of joining the VBSA and to sign up.
News: If your business has announcements, milestones, or projects they would like to share with the VBSA community, please get in touch with us! You can email your news and information to
Call for Seminars: The VBSA is always interested in hosting new workshops and seminars! You can suggest seminar ideas to Rachel Sargent Mirus at
Twitter:  Connect with VBSA on Twitter at
Member Benefit
New Member Benefit: Online Marketplace for Custom Scientific Research Services and Products

BIO has partnered with  - the world's leading online scientific marketplace. The program offers members significant savings in a marketplace populated with 2,600+ suppliers governed by a single legal agreement.  

  Click here for more information